Enact Holdings, Inc. vs CORVEL CORPORATION, two Insurance Brokers stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where ACT and CRVL diverge most: on debt / equity, ACT reads 0.14 and CRVL reads 0.00; on p/b, ACT reads 1.24 and CRVL reads 7.85. The rest of the comparable metrics sit closer together. What ACT's price implies is a bet that sits within the historical range (earnings-power basis). The bull and bear cases for each are in their full reports below.
| Metric | ACT | CRVL |
|---|---|---|
| Price | $47.33 | $59.99 |
| Market cap | $6.6B | $3.1B |
| Sector | Financial Services | Financial Services |
| Stage | Mature | Mature |
| P/E | 10.2 | 28.0 |
| P/B | 1.24 | 7.85 |
| P/S | 5.32 | 3.23 |
| EV/EBITDA | — | 90.1 |
| Revenue growth | +2.0% | +7.1% |
| Gross margin | — | 25.4% |
| Net margin | 54.5% | 11.5% |
| Return on equity | 12.7% | 28.0% |
| Return on assets | 9.7% | 17.2% |
| Dividend yield | 1.7% | — |
| Debt / equity | 0.14 | 0.00 |
| Current ratio | — | 2.03 |
| Piotroski F (quality) | 8 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.